Bacterial meningitis (IDSA 2004): Difference between revisions

From IDWiki
No edit summary
()
Line 10: Line 10:
 
!Antimicrobial therapy
 
!Antimicrobial therapy
 
|-
 
|-
|Age
+
!colspan=3|Age
|
 
|
 
 
|-
 
|-
 
|<1 month
 
|<1 month
Line 30: Line 28:
 
|vanco + 3G ceph + amp
 
|vanco + 3G ceph + amp
 
|-
 
|-
|Head trauma
+
!colspan=3|Head trauma
|
 
|
 
 
|-
 
|-
 
|Basilar skull fracture
 
|Basilar skull fracture

Revision as of 10:51, 2 August 2020

Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84. Epub 2004 Oct 6. doi: 10.1086/425368


Table 4: Empiric Treatment

Population Common pathogens Antimicrobial therapy
Age
<1 month GBS, E.coli, Listeria, Klebsiella amp + cefotax, or
amp + AG
1-23 months S.pneumo, N.mening, GBS, H.flu, E.coli vanco + 3G ceph
2-50 years N.mening, S.pneumo vanco + 3G ceph
>50 years S.pneumo, N.mining, Listeria, GNBs vanco + 3G ceph + amp
Head trauma
Basilar skull fracture S.pneumo, H.flu, GAS vanco + 3G ceph
Penetrating trauma Staph.aureus, CoNS, GNBs vanco + cefep, or
vanco + ceftaz, or
vanco + mero
Post-neurosurgery GNBs, Staph.aureus, CoNS vanco + cefep, or
vanco + ceftaz, or
vanco + mero
CSF shunt CoNS, Staph,aureus, GNBs, P.acnes vanco + cefep, or
vanco + ceftaz, or
vanco + mero